Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis

被引：0
|
作者：
Yasuo Suzuki
Satoshi Motoya
Hiroyuki Hanai
Takayuki Matsumoto
Toshifumi Hibi
Anne M. Robinson
Nael M. Mostafa
Jingdong Chao
Vipin Arora
Anne Camez
Roopal B. Thakkar
Mamoru Watanabe
机构：
[1] Toho University Medical Center Sakura Hospital,IBD Center
[2] Sapporo Kosei General Hospital,Department of Gastroenterology
[3] Hamamatsu South Hospital,undefined
[4] Hyogo College of Medicine,undefined
[5] Kitasato Institute Hospital,undefined
[6] AbbVie,undefined
[7] AbbVie GmbH & Co KG,undefined
[8] Tokyo Medical and Dental University,undefined
来源：
Journal of Gastroenterology | 2014年 / 49卷
关键词：
Clinical remission; Japan; Ulcerative colitis; Mucosal healing; Adalimumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：283 / 294
页数：11
相关论文
共 50 条
  • [1] Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis
    Suzuki, Yasuo
    Motoya, Satoshi
    Hanai, Hiroyuki
    Matsumoto, Takayuki
    Hibi, Toshifumi
    Robinson, Anne M.
    Mostafa, Nael M.
    Chao, Jingdong
    Arora, Vipin
    Camez, Anne
    Thakkar, Roopal B.
    Watanabe, Mamoru
    JOURNAL OF GASTROENTEROLOGY, 2014, 49 (02) : 283 - 294
  • [2] The efficacy and safety of adalimumab for patients with moderately to severely active ulcerative colitis and predictors of response in Korea
    Shin, S. Shin
    Park, S. J.
    Kim, Y.
    Im, J. P.
    Kim, H. J.
    Lee, K. M.
    Kim, J. W.
    Jung, S. A.
    Lee, J.
    Kang, S. B.
    Shin, S. J.
    Kim, E. S.
    Kim, Y. S.
    Kim, T. O.
    Kim, H. S.
    Park, D. I.
    Kim, H. K.
    Kim, E. S.
    Kim, Y. H.
    Kim, D. H.
    Teng, D.
    Kim, J. H.
    Kim, W. Y.
    Choi, C. H.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S432 - S432
  • [3] Comparative Efficacy and Safety of Ozanimod vs Adalimumab and Vedolizumab in Patients with Moderately to Severely Active Ulcerative Colitis
    Dubinsky, Marla C.
    Betts, Keith A.
    LaPensee, Kenneth
    Eren, Devrim
    Kim-Romo, Dawn
    Yin, Lei
    Tang, Wenxi
    Gupte-Singh, Komal
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S314 - S314
  • [4] THE EFFICACY AND SAFETY OF ADALIMUMAB FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS AND PREDICTORS OF RESPONSE IN KOREA.
    Shin, Seung Yong
    Park, Soo Jung
    Kim, Young
    Im, Jong Pil
    Kim, Hyo-Jong
    Lee, Kang-Moon
    Kim, Ji Won
    Jung, Sung-Ae
    Lee, Jun
    Kang, Sang-Bum
    Shin, Sung Jae
    Kim, Eun Sun
    Kim, You Sun
    Kim, Tae Oh
    Kim, Hyun Soo
    Park, Dongil
    Kim, Hyungkil
    Kim, Eun Soo
    Kim, Dohyun
    Teng, Dennis
    Kim, Jong-Hwa
    Kim, Wonyong
    Choi, Chang Hwan
    GASTROENTEROLOGY, 2020, 158 (06) : S1206 - S1206
  • [5] Efficacy and safety of a new vedolizumab subcutaneous formulation in Japanese patients with moderately to severely active ulcerative colitis
    Kobayashi, Taku
    Ito, Hiroaki
    Ashida, Toshifumi
    Yokoyama, Tadashi
    Nagahori, Masakazu
    Inaba, Tomoki
    Shikamura, Mitsuhiro
    Yamaguchi, Takayoshi
    Hori, Tetsuharu
    Pinton, Philippe
    Watanabe, Mamoru
    Hibi, Toshifumi
    INTESTINAL RESEARCH, 2021, 19 (04) : 448 - +
  • [6] Pharmacokinetics of Adalimumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
    Awni, Walid M.
    Eckert, Doerthe
    Sharma, Shringi
    Mostafa, Nael M.
    Noertersheuser, Peter A.
    Pradhan, Rajendra S.
    Robinson, Anne
    Sandborn, William
    Hanauer, Stephen B.
    Colombel, Jean-Frederic
    Thakkar, Roopal
    GASTROENTEROLOGY, 2013, 144 (05) : S229 - S229
  • [7] Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis
    Suzuki, Yasuo
    Motoya, Satoshi
    Hanai, Hiroyuki
    Hibi, Toshifumi
    Nakamura, Shiro
    Lazar, Andreas
    Robinson, Anne Martin
    Skup, Martha
    Mostafa, Nael Mohamed
    Huang, Bidan
    Thakkar, Roopal
    Watanabe, Mamoru
    JOURNAL OF GASTROENTEROLOGY, 2017, 52 (09) : 1031 - 1040
  • [8] COMPARATIVE EFFICACY AND SAFETY OF OZANIMOD AND USTEKINUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
    Dubinsky, Marla C.
    Betts, Keith
    Eren, Devrim
    Tang, Wenxi
    Yin, Lei
    Gupte-Singh, Komal
    GASTROENTEROLOGY, 2022, 162 (07) : S603 - S603
  • [9] Long-Term Efficacy of Adalimumab for Treatment of Moderately to Severely Active Ulcerative Colitis
    Colombel, Jean-Frederic
    Sandborn, William
    Wolf, Doug
    Panaccione, Remo
    Lazar, Andreas
    Kron, Martina
    Robinson, Anne
    Thakkar, Roopal
    INFLAMMATORY BOWEL DISEASES, 2012, 18 : S20 - S21
  • [10] Long-Term Efficacy of Adalimumab for Treatment of Moderately to Severely Active Ulcerative Colitis
    Colombel, Jean-Frederic
    Sandborn, William
    Wolf, Douglas
    Panaccione, Remo
    Lazar, Andreas
    Kron, Martina
    Robinson, Anne
    Thakkar, Roopal
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S652 - S652
12345